Vasculitis & polymyalgia rheumatica

Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

Switching between colchicine preparations seems to be a safe and effective option for BS patients, providing good drug survival rates, patient and physician global scores, and activity scores.

Study context

Population
Behçet's syndrome (BS) patients with mucocutaneous and/or joint involvement with inadequate response to or intolerance of coated colchicine, switched to compressed colchicine 2017–202329 women (64.4%)
Participants
45 patients
Exposure
Switch from coated to compressed colchicine preparation; final visit vs baseline
Outcome
Endpoints: disease activity by BDCAI, patients' and physicians' global VAS (10 cm), and CRP
Methodological detailsretrospective chart review, single-group before–after comparison
  • Retrospective chart review
  • Single-group before–after comparison

Main finding

As reported in the abstract

final visit vs baseline
Still on compressed colchicine during mean follow-up of 32.2 (27) months
30 patients (65.2%)
Patients' global visual analogue scale (VAS), baseline vs final visit
5.8 (2.3) vs 3.7 (3.3); P = 0.008
Physicians' global VAS, baseline vs final visit
4.2 (2.1) vs 2.3 (2.7); P = 0.003
C-reactive protein (CRP), baseline vs final visit
7.2 (10.4) vs 3.6 (5.2); P = 0.039
Mean Behçet's Disease Current Activity Index (BDCAI), baseline vs final visit
2.6 (1.10) vs 2.04 (1.24); P = 0.006

Observational data: associations, not effects.

Further findings

Discontinuation due to inefficacy

Patients discontinued due to inefficacy
6

Safety

Discontinuation due to adverse events

Patients discontinued due to adverse events
7

Original publication

Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome. Rheumatology (Oxford). Published 8 January 2026. doi:10.1093/rheumatology/keag010

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.